Alpex Raises Series B

Alpex Pharma, a Swiss pharmaceutical and nutraceutical tablet manufacturing company, has raised CHF 10.9 million ($9m) in Series B funding. BB Biotech Ventures led the round, and was joined by return backer Signet Healthcare Partners. www.alpex.com